This qualitative analysis of interview results assesses the attributes of “positive deviant” oncology practices that deliver high-quality cancer care at low total cost for testing and adoption by other practices.
This systematic review and meta-analysis compares the incidence and risk of endocrine adverse events following treatment with US Food and Drug Administration-approved immune checkpoint inhibitor regimens.
This cohort study assesses the association of locoregional surgery at diagnosis for small intestine neuroendocrine tumors with survival among Swedish patients.
Using a Markov simulation model based on the United Kingdom Collaborative Trial of Ovarian Cancer Screening clinical trial, this study examines the cost-effectiveness of multimodal screening for ovarian cancer in the United States and the association of screening with mortality.
This phase 2 randomized clinical trial evaluates the effects of pazopanib in combination with paclitaxel vs paclitaxel and placebo on survival in patients with recurrent ovarian cancer.
This validation study compares the American Joint Committee on Cancer eighth edition prognostic stage with the anatomic stage among patients with breast cancer in a single-institution cohort and a large population database.
This systematic review and meta-analysis of 5 randomized clinical trials determines the efficacy of checkpoint inhibitors compared with docetaxel as a second-line therapy for advanced non–small cell lung carcinoma.
This cohort study evaluates the use of positron emission tomography to identify patient phenotypes for androgen receptor expression and glycolysis in patients with metastatic castration-resistant prostate cancer.
This study evaluates the frequency of mismatch repair deficiency testing in adults with colorectal cancer.
This cohort study assesses the comparative effectiveness of adjuvant chemotherapy vs observation for patients with pT3/T4 and/or pN+ urothelial carcinoma of the bladder pretreated with neoadjuvant chemotherapy and radial cystectomy.
This single-arm, phase 2 study of adults with relapsed or refractory B-cell acute lymphoblastic leukemia evaluates the efficacy and safety of treatment with inotuzumab ozogamicin plus low-intensity chemotherapy.
This study investigates anaplastic lymphoma kinase rearrangements in a large series of peritoneal mesothelioma tumors.
This study compares rates of disease progression and overall survival of patients with melanoma treated with propranolol with patients not treated with propranolol.
This study surveys oncologists, hematologists, and practice administrators to gain an understanding of their perceptions of and readiness to participate in the MACRA Quality Payment Program.
This cohort study evaluates the clinical outcomes in patients with metastatic lung cancer treated with PD-1/PD-L1 inhibitors and thoracic radiotherapy.
This study examines the nonresearch payments received by committee and board members of oncology clinical pathway vendors.
This cohort study determines the probability and estimates the time point after diagnosis when death from competing causes becomes more common than that from primary head and neck cancer.
This study examines the association of diagnostic yield and postsurgical recurrence-free survival with restaging abdominopelvic computed tomography performed before surgery after receiving chemoradiotherapy in patients with locally advanced rectal cancer.
This review discusses the development, opportunities, and potential problems of biosimilar cancer drugs.
This JAMA Network Insights article explores the management of the node-positive axilla in breast cancer in 2017.
A woman in her 80s with a history of recurrent oral cancer was diagnosed with squamous cell carcinoma located at the margin of a palatal graft; surveillance imaging reveals metabolic activity in her left vocal cord. What is your diagnosis?
This Viewpoint explores the legislation that allows payment for wastage of injectable medications.
This Viewpoint examines the recent US Food and Drug Administration approval of pembrolizumab and its implications for precision oncology and tumor-type classifications.
Create a personal account or sign in to: